-

SHAREHOLDER ALERT: Robbins LLP Announces that Tarena International, Inc. (TEDU) is Being Sued for Misleading Shareholders

SAN DIEGO & BEIJING--(BUSINESS WIRE)--Shareholder rights law firm Robbins LLP announces that a class action has been filed on behalf of all purchasers of Tarena International, Inc. (NASDAQ: TEDU) who acquired Tarena securities between April 16, 2016 and November 1, 2019. The complaint asserts claims under the Securities Exchange Act of 1934. Tarena provides professional education services in China.

If you suffered a loss due to Tarena International Inc.'s misconduct, click here.

Tarena International, Inc. (TEDU) Made Misstatements Regarding its Accounting Practices

According to the complaint, during the class period, defendants made false and misleading statements and/or failed to disclose that: (1) certain employees were interfering with external audits of the Company's financial statements for certain periods; (2) the Company suffered from revenue and expense inaccuracies; (3) the Company engaged in business transactions with organizations owned, invested in or controlled by Company employees or their family members, which were not properly disclosed; (4) as a result, the Company's financial statements from 2014 through the end of the class period were inaccurate.

On April 30, 2019, Tarena filed a Form NT 20-F Notification of inability to timely file a Form 20-F for the fiscal year ended December 31, 2018, with the SEC. The delay was due, in part, to issues related to "revenue recognition." On May 17, 2019, Tarena filed a Form 6-K with the SEC announcing that it "received a notification letter from Nasdaq Listing Qualifications […] stating the Company was not in compliance with Nasdaq Listing Rule 5250(c)(1) due to its failure to timely file its Annual Report on Form 20-F for the year ended December 31, 2018." On this news, the price of Tarena's ADSs fell 4.8% to close at $3.73 on May 19, 2019.

On July 24, 2019, Tarena filed an update on the audit committee's independent review of the Company's financial statements, indicating that "in addition to the financial results for 2018, the Registrant also expects that its historical disclosure of its financial results and audited financial statements for its fiscal year ended December 31, 2017, as well as the financial results and audited financial statements for periods prior to 2017, may need to be restated and should not be relied upon, pending completion of the Independent Audit Committee Review." On this news, the price of Tarena's ADSs fell 4.7% to close at $1.63 per share on July 25, 2019. The Company announced the results of its independent investigation on November 1, 2019. Its findings included expense inaccuracies and irregularities, conflicts of interest, and interference with external audit processes, among other things. On this news, the price of Tarena ADSs dropped 9.4% to open on November 4, 2019, at $0.76.

If you purchased shares of Tarena International, Inc. (TEDU) between April 16, 2016 and November 1, 2019, you have until August 23, 2021, to ask the court to appoint you lead plaintiff for the class.

All representation is on a contingency fee basis. Shareholders pay no fees or expenses.

Contact us to learn more:

Lauren Levi
(800) 350-6003
llevi@robbinsllp.com
Shareholder Information Form

Robbins LLP is a nationally recognized leader in shareholder rights law. To be notified if a class action against Tarena International, Inc. settles or to receive free alerts when corporate executives engage in wrongdoing, sign up for Stock Watch today.

Attorney Advertising. Past results do not guarantee a similar outcome.

Contacts

Lauren Levi
Robbins LLP
5040 Shoreham Place
San Diego, CA 92122
llevi@robbinsllp.com
(800) 350-6003
www.robbinsllp.com

Robbins LLP

NASDAQ:TEDU

Release Versions
$Cashtags

Contacts

Lauren Levi
Robbins LLP
5040 Shoreham Place
San Diego, CA 92122
llevi@robbinsllp.com
(800) 350-6003
www.robbinsllp.com

Social Media Profiles
More News From Robbins LLP

Investor Notice: Shareholder Rights Law Firm Robbins LLP Informs Investors of the uniQure N.V. Securities Class Action Lawsuit

SAN DIEGO--(BUSINESS WIRE)--Robbins LLP informs stockholders that a class action was filed on behalf of all investors who purchased or otherwise acquired uniQure N.V. (NASDAQ: QURE) ordinary shares between September 24, 2025 and October 31, 2025. uniQure is a biotechnology company developing gene therapies for rare diseases. For more information, submit a form, email attorney Aaron Dumas, Jr., or give us a call at (800) 350-6003. The Allegations: Robbins LLP is Investigating Allegations that un...

Investor Notice: Shareholder Rights Law Firm Robbins LLP Informs Investors of the POMDoctor Ltd. Securities Class Action Lawsuit

SAN DIEGO--(BUSINESS WIRE)--Robbins LLP informs stockholders that a class action was filed on behalf of all investors who purchased or otherwise acquired POMDoctor, Ltd. (NASDAQ: POM) securities between October 9, 2025 and December 11, 2025. POMDoctor claims to be "a leading online medical services platform for chronic diseases in China." For more information, submit a form, email attorney Aaron Dumas, Jr., or give us a call at (800) 350-6003. The Allegations: Robbins LLP is Investigating Alleg...

Investor Notice: Shareholder Rights Law Firm Robbins LLP Informs Investors of the Inovio Pharmaceuticals, Inc. Class Action Lawsuit

SAN DIEGO--(BUSINESS WIRE)--Robbins LLP informs stockholders that a class action was filed on behalf of all persons that purchased or otherwise acquired Inovio Pharmaceuticals, Inc. (NASDAQ: INO) securities between October 10, 2023 and December 26, 2025. Inovio is a biotechnology company focused on the discovery, development, and commercialization of DNA medicines to treat and protect people from diseases associated with, inter alia, human papillomavirus (“HPV”). For more information, submit a...
Back to Newsroom